GSK and Novartis settle over Augmentin
October 29, 2003GlaxoSmithKline has reached an agreement with Novartis in its court action over stolen trade secrets for its antibiotic Augmentin.Novartis will …
OGS withdraws CAT offer recommendation
October 29, 2003Oxford GlycoSciences has withdrawn its support of Cambridge Antibody Technology's £110 million all-share bid for the company, despite believing a …
Foundation hospitals survive Labour revolt
October 29, 2003Plans for foundation hospitals have been narrowly passed by the House of Commons despite a revolt by Labour MPs that …
Schering’s Angeliq approved in Europe
October 29, 2003Schering's new low dose HRT product Angeliq has gained mutual recognition in the European Union, with launches expected across the …
Pharma urged to reduce animal testing
October 29, 2003The pharmaceutical industry should test more drugs in humans at a pre-clinical stage to reduce numbers of primates used, a …
Blockbuster combination unveiled as Pfizer marches on
October 29, 2003Pfizer is to launch a new double-blockbuster cardiovascular product to help further its position as the Goliath of the pharmaceutical …
Profits continue to plummet at Schering-Plough
October 29, 2003Schering-Plough has issued its third earnings warning this year as it continues to suffer under an onslaught from generic competition.The …
Faster market access for generics in US
October 29, 2003Laws governing the entry of generic drugs on the US market are to be streamlined in an effort to cut …
AstraZeneca rises on Crestor hopes
October 29, 2003AstraZeneca made significant stock market gains following indications its new superstatin Crestor will receive a positive review from US regulatory …
Elan sues King Pharma over drug sales
October 29, 2003Elan, King Pharmaceuticals
Elan is taking legal action to force King Pharmaceuticals to buy two drugs it urgently needs to divest to help …
GSK gives way on Paxil patents
October 29, 2003New measures by the FDA to speed up patient access to generic medicines have claimed their first scalp after GlaxoSmithKline …
BMA elects new leader
October 29, 2003A consultant surgeon at Halton Hospital in Cheshire has been elected as new Chairman of the BMA to replace Dr …
MHRA must engage more with public, say MPs
October 29, 2003The MHRA has come under criticism from MPs over its efforts to communicate with the public and lead improvements in …
Schering-Plough plays down Zetia label change
October 29, 2003Schering-Plough has changed the labelling of its new cholesterol absorbing drug Zetia after some patients reported experiencing hypersensitivity reactions, including …
Pharma executive proves controversial choice for AIDS leader
October 29, 2003President George Bush has appointed Randy Tobias, former chief executive of Eli Lilly, to lead US efforts to combat AIDS …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
